More attention for high-risk pathological features for stage Ⅱ colorectal cancer required / 中华病理学杂志
Chinese Journal of Pathology
; (12): 773-777, 2023.
Article
en Zh
| WPRIM
| ID: wpr-1012306
Biblioteca responsable:
WPRO
ABSTRACT
Stage Ⅱ (T3-4N0M0) accounts for 25% of colorectal cancer and five-year survival is between 70% and 80%. However, 25% of patients develop distant metastases and have a survival rate similar to that of stage Ⅲ disease. However, whether or not to give adjuvant chemotherapy is still a controversial issue. As a result, there has been a lot of interest in the identification of the pathological factors underlying the poor prognosis associated with this stage, in order to establish a firmer basis for the administration of adjuvant chemotherapy. But not all high-risk factors are equal for stage Ⅱ colorectal cancer, variability still exists in the management and outcomes of high-risk patients. Here be introduced and commented on thinking and understanding about its controversy and evolution for the attention of the working pathologist and gastroenterologist doctors.
Texto completo:
1
Base de datos:
WPRIM
Asunto principal:
Pronóstico
/
Neoplasias Colorrectales
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Factores de Riesgo
/
Quimioterapia Adyuvante
/
Estadificación de Neoplasias
Límite:
Humans
Idioma:
Zh
Revista:
Chinese Journal of Pathology
Año:
2023
Tipo del documento:
Article